glucose, (beta-d)-isomer has been researched along with Myocardial Infarction in 75 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (2.67) | 18.7374 |
| 1990's | 1 (1.33) | 18.2507 |
| 2000's | 5 (6.67) | 29.6817 |
| 2010's | 32 (42.67) | 24.3611 |
| 2020's | 35 (46.67) | 2.80 |
| Authors | Studies |
|---|---|
| Breyer, RM; Ji, Y; Kong, D; Lazarus, M; Liu, G; Lu, A; Nakamura, M; Shen, Y; Stratakis, CA; Yu, Y; Zuo, S | 1 |
| Kus, M; Tanda, K; Williams, FM; Williams, TJ | 1 |
| Frank, P; Kieffer, L; Lévy, A | 1 |
| Bessette, LG; Brodovicz, KG; Déruaz-Luyet, A; Glynn, RJ; Najafzadeh, M; Paik, JM; Patorno, E; Pawar, A; Schneeweiss, S; Wexler, DJ | 1 |
| Brand, SB; Kansal, AR; Koitka-Weber, A; Kuti, E; Pfarr, E; Reifsnider, OS; Stargardter, M; Ustyugova, A; Wang, C; Wanner, C | 1 |
| Andres, AM; Germano, JF; Gottlieb, RA; Huang, C; Mentzer, RM; Sin, J; Song, Y; Taylor, DJR; Thakur, R | 1 |
| Aylward, P; Bhatt, DL; Cahn, A; Dalby, AJ; Dellborg, M; Dimulescu, D; Furtado, RHM; Gause-Nilsson, I; Goodrich, EL; Langkilde, AM; Leiter, LA; McGuire, DK; Mosenzon, O; Murphy, SA; Nicolau, JC; Oude Ophuis, AJM; Raz, I; Sabatine, MS; Wilding, JPH; Wiviott, SD | 1 |
| Anker, SD; Bhatt, DL; Butler, J; Harrington, J; Hernandez, AF; Jones, WS; Petrie, MC; Sumin, M; Udell, JA; Vedin, O; Zwiener, I | 1 |
| Chen, X; Fan, ZG; Ji, MY; Ma, GS; Xu, Y | 1 |
| Liu, Z; Zhang, H | 1 |
| Bhatt, DL; Cahn, A; Dwyer, JP; Fredriksson, M; Gause-Nilsson, IAM; Goodrich, EL; Heerspink, HJL; Johansson, PA; Langkilde, AM; Leiter, LA; McGuire, DK; Mosenzon, O; Murphy, SA; Raz, I; Rozenberg, A; Sabatine, MS; Schechter, M; Wilding, JPH; Wiviott, SD; Yanuv, I; Zelniker, TA | 1 |
| Chen, F; Deng, R; Jiang, K; Liang, J; Lu, Y; Miao, Y; Qian, J; Shen, L; Su, F; Wang, D; Xiang, Y | 1 |
| Anker, S; Butler, J; Harrington, J | 1 |
| Ji, Y; Sun, L; Wang, FF; Yan, XJ; Zhang, JL; Zhu, Y | 1 |
| Chen, F; Chen, K; Hwa, J; Jiang, K; Qian, J; Wang, D; Wang, H; Wu, Y; Xiang, Y; Xu, Y; Yang, B; Yu, Y; Zhou, C | 1 |
| Alexander, J; Fukumitsu, M; Kawada, T; Li, M; Matsushita, H; Nishiura, A; Saku, K; Uemura, K; Yokota, S; Yoshida, Y | 1 |
| Bergenstal, RM; Fitchett, D; George, JT; Hantel, S; Inzucchi, SE; Kaspers, S; Kiš, SG; Monteiro, P; Toural, E; Zinman, B | 1 |
| Li, Y; Lin, X; Tong, L; Wu, F; Wu, X; Wu, Y; Ye, B | 1 |
| Li, J; Li, X; Liu, J; Lu, Q; Ren, D; Sun, X; Tong, N; Zhang, J | 1 |
| Hirose, M; Ibi, M; Ishida, N; Matsushita, N; Morino, Y; Saito, M; Sawa, Y; Taira, E | 1 |
| Chen, P; Han, B; Liu, J; Ruan, H; Wu, P; Yimei, D; Zhang, M | 1 |
| Ablasser, K; Alber, H; Berger, R; Kaulfersch, C; Kolesnik, E; Leitner, K; Lichtenauer, M; Mader, A; Moertl, D; Oulhaj, A; Pferschy, PN; Reiter, C; Rieder, T; Saely, CH; Sailer, S; Siller-Matula, J; Sourij, H; Tripolt, NJ; Verheyen, N; von Lewinski, D; Weidinger, F; Zechner, PM | 1 |
| Advani, A; Batchu, SN; Connelly, KA; Desjardins, JF; Gilbert, RE; Kabir, G; Nghiem, L; Thai, K; Visram, A; Yerra, VG; Zhang, Y | 1 |
| de Boer, RA; de Menezes Montenegro, L; Heerspink, HJL; Hillebrands, JL; Oberdorf-Maass, SU; Silljé, HHW; van Goor, H; Westenbrink, BD; Yurista, SR | 1 |
| Brueckmann, M; Butler, J; Fitchett, D; George, JT; Inzucchi, SE; Mazer, CD; Ofstad, AP; Sharma, A; Verma, S; Wanner, C; Zinman, B; Zwiener, I | 1 |
| Kimura, Y; Kuno, A; Miki, T; Miura, T; Mizuno, M; Moniwa, N; Oshima, H; Sato, T; Tanaka, M; Tanno, M; Yano, T | 1 |
| Ivkin, D; Karpov, A; Kaschina, E; Krasnova, M; Kulikov, A; Okovityi, S; Smirnov, A | 1 |
| Apaijai, N; Chattipakorn, N; Chattipakorn, SC; Jaiwongkam, T; Kerdphoo, S; Lahnwong, S; Palee, S; Sriwichaiin, S | 1 |
| Badimon, JJ; Garcia-Ropero, A; Ishikawa, K; Picatoste, B; Requena-Ibanez, JA; Santos-Gallego, CG; Sanz, J; Tunon, J; Vargas-Delgado, AP | 1 |
| Asensio Lopez, MDC; Bayes-Genis, A; Fernandez Del Palacio, MJ; Hernandez Vicente, A; Hernandez-Martinez, A; Lax, A; Pascual Figal, DA; Saura Guillen, E | 1 |
| Hu, NB; Jin, P; Li, LH; Shi, Y | 1 |
| Dibrov, E; Kura, B; Netticadan, T; O'Hara, KA; Parikh, M; Pierce, GN; Slezak, J | 1 |
| Asai, K; Hoshika, Y; Ishikawa, M; Iwasaki, YK; Kodani, E; Kubota, Y; Maruyama, M; Miyamoto, M; Miyauchi, Y; Mozawa, K; Ogano, M; Shimizu, W; Takano, H; Tanabe, J; Tara, S; Tokita, Y; Tsukada, Y; Yamamoto, T; Yodogawa, K | 1 |
| George, JT; Hantel, S; Koitka-Weber, A; Levin, A; Perkovic, V; von Eynatten, M; Wanner, C; Wheeler, DC | 1 |
| Kang, L; Liu, Y; Wu, M; Xu, B; Xu, J | 1 |
| Abdel-Kareem, MA; Ahmed, AS; Elsisy, RA; Mona, MM | 1 |
| Bøtker, HE; Hansen, J; Hjortbak, MV; Jespersen, NR; Kvist, F; Lassen, TR; Seefeldt, JM | 1 |
| Atar, S; Bandel, N; Daud, E; Ertracht, O; Moady, G; Reuveni, T; Shehadeh, M | 1 |
| Chen, SY; Chen, WT; Lee, CC; Lee, TM | 1 |
| Asai, K; Hoshika, Y; Iwasaki, YK; Kodani, E; Kubota, Y; Maruyama, M; Miyamoto, M; Miyauchi, Y; Mozawa, K; Shimizu, W; Takano, H; Tanabe, J; Tara, S; Tokita, Y; Tsukada, Y; Yamamoto, T; Yodogawa, K | 1 |
| Cheng, KK; Ghosh, S; Gokhale, K; Hanif, W; Kumarendran, B; Marshall, T; Narendran, P; Nirantharakumar, K; Thomas, GN; Toulis, KA; Willis, BH | 1 |
| Chilton, RJ | 1 |
| Das, S; Devkar, R; Jana, S; Mandal, R; Patel, D; Patel, S; Thadani, J; Upadhyay, K | 1 |
| Grewal, G; Kirby, C; McCallum, JL; Netticadan, T; Raj, P; Wigle, JT; Yu, L | 1 |
| Chattipakorn, N; Chattipakorn, SC; Sa-Nguanmoo, P; Siri-Angkul, N; Sivasinprasasn, S; Tanajak, P; Thummasorn, S | 1 |
| Chen, H; Dong, Y; He, X; Li, J; Wang, J | 1 |
| Kimura, Y; Kuno, A; Miki, T; Miura, T; Mizuno, M; Nakata, K; Oshima, H; Sato, T; Tanno, M; Yano, T | 1 |
| Connelly, KA; Desjardins, JF; Gilbert, RE; Thai, K; Zhang, Y | 1 |
| Cao, D; Chen, G; Guo, D; Jin, M; Liu, G; Yuan, X | 1 |
| Abe, K; Kimura, Y; Kuno, A; Miki, T; Miura, T; Mizuno, M; Nakata, K; Ohwada, W; Oshima, H; Sato, T; Tanno, M; Yano, T | 1 |
| Baartscheer, A; Buchholtz, N; Coronel, R; Eerbeek, O; Hollmann, MW; Nederlof, R; Schumacher, C; Uthman, L; Weber, NC; Zuurbier, CJ | 1 |
| Bhatt, DL; Bonaca, MP; Cahn, A; Fredriksson, M; Furtado, RHM; Gause-Nilsson, IAM; Kuder, J; Langkilde, AM; Leiter, LA; McGuire, DK; Mosenzon, O; Murphy, SA; Nicolau, JC; Raz, I; Ruff, CT; Sabatine, MS; Wilding, JPH; Wiviott, SD; Zelniker, TA | 1 |
| de Boer, RA; Hillebrands, JL; Oberdorf-Maass, SU; Pavez Giani, MG; Schouten, EM; Silljé, HHW; van Goor, H; van Veldhuisen, DJ; Westenbrink, BD; Yurista, SR | 1 |
| Polovina, MM; Seferović, JP; Seferović, PM | 1 |
| Austria, JA; Garg, B; Netticadan, T; Parikh, M; Pierce, GN; Raj, P; Yu, L | 1 |
| Packer, M | 1 |
| Gilinsky, MA; Komarova, NI; Latysheva, TV; Naumenko, SE; Rogachev, AD; Salakhutdinov, NF; Tolstikov, GA | 1 |
| Alperin, P; Cohen, M; Dziuba, J; Goswami, D; Grossman, HL; Hardy, E; Iloeje, U; Perlstein, I; Racketa, J | 1 |
| Chen, C; Gao, J; Gao, Y; Guo, J; Wang, H; Wu, R | 1 |
| Chen, C; Du, P; Wang, J | 1 |
| Du, G; Liu, Y; Ren, M; Tian, J; Wang, X | 1 |
| Stiefelhagen, P | 1 |
| Duan, W; Hua, F; Li, H; Song, F; Sun, J; Wang, S; Xie, Y; Yan, L; Yang, Q; Zhou, X | 1 |
| Duan, J; Guo, Y; Hou, L; Hu, J; Lin, J; Man, W; Shen, M; Sun, D; Wang, H; Zhang, D; Zhang, M; Zhang, Y; Zhao, Z | 1 |
| George, J; Kaku, K; Kaspers, S; Lee, J; Mattheus, M; Woerle, HJ | 1 |
| Chang, NC; Lee, TM; Lin, SZ | 1 |
| Hong, D; Wu, L; Yang, J; Yang, X; Yu, J; Zeng, X | 1 |
| Ao, H; Gao, XF; Shi, HM; Sun, T | 1 |
| Jiang, WL; Liu, HZ; Tang, XX; Zhang, SM | 1 |
| Fan, R; He, J; Huang, X; Liu, Z; Qin, F; Ren, P; Tang, T; Wang, Y; Zhang, C; Zhang, H; Zhou, H; Zhu, Z | 1 |
| Hou, J; Jiang, WL; Kang, ZC; Xu, Y; Zhu, HB | 1 |
| Koneru, S; Maulik, N; Penumathsa, SV; Prasad, K; Thirunavukkarasu, M; Zhan, L | 1 |
| John, S; Koneru, S; Maulik, N; Menon, VP; Penumathsa, SV; Prasad, K; Zhan, L | 1 |
| Cui, F; Wang, YP; Yang, CY; Zhang, LP; Zhang, Y | 1 |
| Bokarev, IN; Golikov, AP; Lusov, VA; Ptushkin, VV; Savenkov, MP; Seregina, MV; Zvereva, TV | 1 |
13 trial(s) available for glucose, (beta-d)-isomer and Myocardial Infarction
| Article | Year |
|---|---|
Cost-Effectiveness of Empagliflozin in Patients With Diabetic Kidney Disease in the United States: Findings Based on the EMPA-REG OUTCOME Trial.
Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Cost-Benefit Analysis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucose; Glucosides; Heart Failure; Humans; Hypoglycemic Agents; Medicare; Myocardial Infarction; United States | 2022 |
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
Topics: Acute Kidney Injury; Aged; Benzhydryl Compounds; Blood Pressure; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Empagliflozin in patients post myocardial infarction rationale and design of the EMPACT-MI trial.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Double-Blind Method; Glucosides; Heart Failure; Humans; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Ventricular Dysfunction, Left | 2022 |
Dapagliflozin and Prevention of Kidney Disease Among Patients With Type 2 Diabetes: Post Hoc Analyses From the DECLARE-TIMI 58 Trial.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glomerular Filtration Rate; Glucose; Glucosides; Humans; Myocardial Infarction; Sodium; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Efficacy and safety of empagliflozin in older patients in the EMPA-REG OUTCOME® trial.
Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Stroke | 2019 |
Impact of EMpagliflozin on cardiac function and biomarkers of heart failure in patients with acute MYocardial infarction-The EMMY trial.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Double-Blind Method; Echocardiography; Glucosides; Glycated Hemoglobin; Heart Failure; Hospitalization; Humans; Ketone Bodies; Length of Stay; Mortality; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Empagliflozin reduces the risk of mortality and hospitalization for heart failure across Thrombolysis In Myocardial Infarction Risk Score for Heart Failure in Diabetes categories: Post hoc analysis of the EMPA-REG OUTCOME trial.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glucosides; Heart Failure; Hospitalization; Humans; Myocardial Infarction; Risk Factors; Thrombolytic Therapy | 2020 |
Effects of empagliflozin versus placebo on cardiac sympathetic activity in acute myocardial infarction patients with type 2 diabetes mellitus: the EMBODY trial.
Topics: 3-Iodobenzylguanidine; Aged; Benzhydryl Compounds; Blood Pressure; Body Weight; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Double-Blind Method; Electrocardiography, Ambulatory; Female; Glucosides; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Parasympathetic Nervous System; Radionuclide Imaging; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Sympathetic Nervous System; Uric Acid | 2020 |
Empagliflozin and Cardiovascular and Kidney Outcomes across KDIGO Risk Categories:
Topics: Adams-Stokes Syndrome; Aged; Albuminuria; Benzhydryl Compounds; Cardiovascular Diseases; Creatinine; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Genital Diseases, Female; Genital Diseases, Male; Glomerular Filtration Rate; Glucosides; Heart Failure; Hospitalization; Humans; Infections; Male; Middle Aged; Mortality; Myocardial Infarction; Placebos; Renal Insufficiency, Chronic; Sodium-Glucose Transporter 2 Inhibitors | 2020 |
Effect of Empagliflozin Versus Placebo on Body Fluid Balance in Patients With Acute Myocardial Infarction and Type 2 Diabetes Mellitus: Subgroup Analysis of the EMBODY Trial.
Topics: Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Heart Failure; Humans; Myocardial Infarction; Prospective Studies; Water-Electrolyte Balance | 2022 |
Dapagliflozin and Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus and Previous Myocardial Infarction.
Topics: Aged; Benzhydryl Compounds; Brain Ischemia; Cause of Death; Diabetes Mellitus, Type 2; Disease Progression; Double-Blind Method; Female; Glucosides; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Assessment; Risk Factors; Sodium-Glucose Transporter 2 Inhibitors; Stroke; Time Factors; Treatment Outcome | 2019 |
[Empagliflozin improves cardiovascular prognosis].
Topics: Benzhydryl Compounds; Cause of Death; Diabetes Complications; Diabetes Mellitus, Type 2; Germany; Glucosides; Humans; Hypoglycemic Agents; Myocardial Infarction; Survival Rate | 2016 |
Empagliflozin and Cardiovascular Outcomes in Asian Patients With Type 2 Diabetes and Established Cardiovascular Disease - Results From EMPA-REG OUTCOME
Topics: Aged; Asian People; Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Stroke; Treatment Outcome | 2017 |
62 other study(ies) available for glucose, (beta-d)-isomer and Myocardial Infarction
| Article | Year |
|---|---|
PKA regulatory IIα subunit is essential for PGD2-mediated resolution of inflammation.
Topics: Animals; Cecum; Cell Polarity; Cyclic AMP-Dependent Protein Kinase RIIalpha Subunit; Disease Models, Animal; Female; Gene Deletion; Hydantoins; Inflammation; Janus Kinase 2; Ligation; Macrophages; Mice, Inbred C57BL; Myocardial Infarction; Myocardial Ischemia; Peritonitis; Prostaglandin D2; Protein Binding; Protein Subunits; Punctures; Receptors, Immunologic; Receptors, Interferon; Receptors, Prostaglandin; Signal Transduction; STAT1 Transcription Factor; Wound Healing; Zymosan | 2016 |
Trimetazidine inhibits neutrophil accumulation after myocardial ischaemia and reperfusion in rabbits.
Topics: Animals; Blood Pressure; Capillary Permeability; Disease Models, Animal; Heart Rate; Interleukin-8; Leukotriene B4; Male; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Neutrophils; Rabbits; Trimetazidine; Zymosan | 1993 |
[Disorders in left ventricle repolarization during acute cytosteatonecrotic pancreatitis. Electrocardiographic course under the effect of antienzymes].
Topics: Acute Disease; Adult; Amylases; Cardiomyopathies; Electrocardiography; Heart Conduction System; Humans; Hyperlipidemias; Ischemia; Lipase; Liver Function Tests; Male; Myocardial Infarction; Pancreas; Pancreatitis; Zymosan | 1969 |
Effectiveness and safety of empagliflozin in routine care patients: Results from the EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study.
Topics: Adult; Aged; Benzhydryl Compounds; Cardiovascular Diseases; Cohort Studies; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucosides; Humans; Medicare; Middle Aged; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; United States | 2022 |
Attenuation of Adverse Postinfarction Left Ventricular Remodeling with Empagliflozin Enhances Mitochondria-Linked Cellular Energetics and Mitochondrial Biogenesis.
Topics: Animals; Benzhydryl Compounds; Electrocardiography; Energy Metabolism; Glucosides; Mice, Inbred C57BL; Mice, Knockout; Mitochondria, Heart; Mitophagy; Myocardial Infarction; Organelle Biogenesis; Ubiquitin-Protein Ligases; Ventricular Remodeling | 2021 |
Appropriate Dose of Dapagliflozin Improves Cardiac Outcomes by Normalizing Mitochondrial Fission and Reducing Cardiomyocyte Apoptosis After Acute Myocardial Infarction.
Topics: Animals; Apoptosis; Benzhydryl Compounds; Glucosides; Mitochondrial Dynamics; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley | 2022 |
Effects of Dapagliflozin in Combination with Metoprolol Sustained-Release Tablets on Prognosis and Cardiac Function in Patients with Acute Myocardial Infarction after PCI.
Topics: Benzhydryl Compounds; Biomarkers; C-Reactive Protein; Delayed-Action Preparations; Drug Therapy, Combination; Glucosides; Humans; Interleukin-6; Metoprolol; Myocardial Infarction; Percutaneous Coronary Intervention; Prognosis; Serum Albumin; Stroke Volume; Superoxide Dismutase; Tablets; Ventricular Function, Left | 2022 |
Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia.
Topics: Animals; Beclin-1; Benzhydryl Compounds; Glucosides; Hyperglycemia; Mice; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Putting the puzzle together: SGLT2 inhibitors from prevention to treatment of heart failure.
Topics: Glucosides; Heart Failure; Humans; Myocardial Infarction; Sodium-Glucose Transporter 2 Inhibitors | 2022 |
Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
Topics: Benzhydryl Compounds; Glucose; Glucosides; Heart Failure; Humans; Myocardial Infarction; Neprilysin; Percutaneous Coronary Intervention; Prognosis; Receptors, Angiotensin; Retrospective Studies; Triglycerides | 2022 |
Bone marrow-derived naïve B lymphocytes improve heart function after myocardial infarction: a novel cardioprotective mechanism for empagliflozin.
Topics: Animals; B-Lymphocytes; Benzhydryl Compounds; Bone Marrow; Glucosides; Heart Failure; Immunoglobulin D; Immunoglobulin M; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Percutaneous Coronary Intervention; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling | 2022 |
Acute effects of empagliflozin on open-loop baroreflex function and urinary glucose excretion in rats with chronic myocardial infarction.
Topics: Animals; Baroreflex; Glucose; Glucosides; Myocardial Infarction; Rats | 2023 |
Paeoniflorin on Rat Myocardial Ischemia Reperfusion Injury of Protection and Mechanism Research.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Cardiotonic Agents; Caspase 3; Glucosides; Male; MAP Kinase Signaling System; Medicine, Chinese Traditional; Monoterpenes; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Random Allocation; Rats; Rats, Sprague-Dawley | 2020 |
Empagliflozin attenuates ischemia and reperfusion injury through LKB1/AMPK signaling pathway.
Topics: AMP-Activated Protein Kinases; Animals; Benzhydryl Compounds; Cell Hypoxia; Glucosides; Ischemia; Male; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Protein Serine-Threonine Kinases; Signal Transduction | 2020 |
Pretreatment with KGA-2727, a selective SGLT1 inhibitor, is protective against myocardial infarction-induced ventricular remodeling and heart failure in mice.
Topics: Animals; Fibrosis; Gene Expression Regulation; Glucosides; Heart Failure; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Pyrazoles; RNA, Messenger; Sodium-Glucose Transporter 1; Ventricular Remodeling | 2020 |
Protective effects of Salidroside on cardiac function in mice with myocardial infarction.
Topics: Animals; Apoptosis; Cardiotonic Agents; Coronary Vessels; Cytokines; Disease Models, Animal; Fibrosis; Glucosides; Heart; Ligation; Male; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Neovascularization, Physiologic; Phenols; Ventricular Remodeling | 2019 |
Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction.
Topics: Animals; Benzhydryl Compounds; Calcium Signaling; Disease Models, Animal; Glucosides; Heart Failure; Myocardial Infarction; Myocardium; Rats, Inbred F344; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Ventricular Function, Left; Ventricular Pressure | 2020 |
Effects of Sodium-Glucose Co-transporter 2 Inhibition with Empaglifozin on Renal Structure and Function in Non-diabetic Rats with Left Ventricular Dysfunction After Myocardial Infarction.
Topics: Animals; Benzhydryl Compounds; Biomarkers; Disease Models, Animal; Diuresis; Glucosides; Kidney; Male; Myocardial Infarction; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Empagliflozin attenuates acute kidney injury after myocardial infarction in diabetic rats.
Topics: Acute Kidney Injury; Animals; Benzhydryl Compounds; Diabetes Complications; Diabetes Mellitus, Experimental; Glucosides; Kidney; Male; Myocardial Infarction; Rats | 2020 |
Comparative efficacy of empagliflozin and drugs of baseline therapy in post-infarct heart failure in normoglycemic rats.
Topics: Animals; Benzhydryl Compounds; Bisoprolol; Cardiovascular Agents; Chronic Disease; Disease Models, Animal; Exercise Tolerance; Fosinopril; Glucosides; Heart Failure; Male; Myocardial Infarction; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Spironolactone; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Acute dapagliflozin administration exerts cardioprotective effects in rats with cardiac ischemia/reperfusion injury.
Topics: Animals; Apoptosis; Arrhythmias, Cardiac; Benzhydryl Compounds; Disease Models, Animal; Energy Metabolism; Glucosides; Male; Mitochondria, Heart; Mitochondrial Dynamics; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Correlation between myocardial strain and adverse remodeling in a non-diabetic model of heart failure following empagliflozin therapy.
Topics: Animals; Benzhydryl Compounds; Glucosides; Heart Failure; Humans; Myocardial Infarction; Myocardium; Sodium-Glucose Transporter 2 Inhibitors; Swine; Ventricular Function, Left | 2020 |
Empagliflozin improves post-infarction cardiac remodeling through GTP enzyme cyclohydrolase 1 and irrespective of diabetes status.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Experimental; Glucosides; GTP Cyclohydrolase; Male; Myocardial Infarction; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Remodeling | 2020 |
Salidroside inhibits apoptosis and autophagy of cardiomyocyte by regulation of circular RNA hsa_circ_0000064 in cardiac ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Autophagy; Gene Expression Regulation; Glucosides; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Oxidative Stress; Phenols; Plant Extracts; Rats; Rats, Wistar; Reperfusion Injury; Rhodiola; RNA, Circular; Superoxide Dismutase | 2021 |
Cardioprotective Effects of Dietary Flaxseed Post-Infarction Are Associated with Changes in MicroRNA Expression.
Topics: alpha-Linolenic Acid; Animal Feed; Animals; Butylene Glycols; Collagen Type I; Disease Models, Animal; Fatty Acids; Flax; Glucosides; Homeodomain Proteins; Male; MicroRNAs; Myocardial Infarction; Rats, Sprague-Dawley; Seeds; Up-Regulation | 2020 |
Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic mice.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus; Glucosides; Humans; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocytes, Cardiac | 2021 |
SGLT2 inhibitor empagliflozin monotherapy alleviates renal oxidative stress in albino Wistar diabetic rats after myocardial infarction induction.
Topics: Acute Kidney Injury; Animals; Benzhydryl Compounds; Cell Adhesion Molecules; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Electrocardiography; Glucosides; Kidney; Lipocalin-2; Male; Myocardial Infarction; Oxidative Stress; Rats; Rats, Wistar; RNA, Messenger; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
Cardioprotective effects of empagliflozin after ischemia and reperfusion in rats.
Topics: Animals; Benzhydryl Compounds; Cardiotonic Agents; Glucosides; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Sprague-Dawley; Sodium-Glucose Transporter 2 Inhibitors | 2021 |
The impact of empagliflozin on cardiac physiology and fibrosis early after myocardial infarction in non-diabetic rats.
Topics: Animals; Benzhydryl Compounds; Collagen; Disease Models, Animal; Fibrosis; Glucosides; Hydroxyproline; Male; Myocardial Infarction; Myocardium; Rats, Sprague-Dawley; Smad3 Protein; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Time Factors; Transforming Growth Factor beta1; Ventricular Function, Left | 2021 |
Dapagliflozin attenuates arrhythmic vulnerabilities by regulating connexin43 expression via the AMPK pathway in post-infarcted rat hearts.
Topics: AMP-Activated Protein Kinases; Animals; Arrhythmias, Cardiac; Benzhydryl Compounds; Connexin 43; Gene Expression; Glucosides; Male; Myocardial Infarction; Rats; Rats, Wistar; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Remodeling | 2021 |
All-Cause Mortality in Patients With Diabetes Under Treatment With Dapagliflozin: A Population-Based, Open-Cohort Study in The Health Improvement Network Database.
Topics: Aged; Benzhydryl Compounds; Cardiovascular Diseases; Case-Control Studies; Cause of Death; Cohort Studies; Databases, Factual; Diabetes Mellitus, Type 2; Female; Glucosides; Heart Failure; Humans; Hypoglycemic Agents; Ischemic Attack, Transient; Male; Middle Aged; Mortality; Myocardial Infarction; Myocardial Ischemia; Retrospective Studies; Stroke; Ventricular Dysfunction, Left | 2017 |
Introduction.
Topics: Benzhydryl Compounds; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Glucosides; Heart Failure; Hospitalization; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Secondary Prevention; Sodium-Glucose Transporter 2 Inhibitors; Stroke | 2017 |
Anthocyanin rich extract of Brassica oleracea L. alleviates experimentally induced myocardial infarction.
Topics: Animals; Animals, Newborn; Anthocyanins; Antioxidants; Apoptosis; Brassica; Caveolin 3; Gene Expression Profiling; Glucosides; Humans; Hydrogen Peroxide; Isoproterenol; Male; Molecular Docking Simulation; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Plant Extracts; Rats; RNA, Messenger; Sarcoplasmic Reticulum Calcium-Transporting ATPases | 2017 |
Effects of cyanidin 3-0-glucoside on cardiac structure and function in an animal model of myocardial infarction.
Topics: Animals; Anthocyanins; Disease Models, Animal; Glucosides; Heart; Humans; Male; Myocardial Infarction; Myocardium; Oryza; Oxidative Stress; Plant Extracts; Rats; Rats, Sprague-Dawley | 2017 |
Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.
Topics: Animals; Benzhydryl Compounds; Cardiotonic Agents; Cytoprotection; Diet, High-Fat; Glucosides; Heart; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Rats; Rats, Wistar; Ventricular Dysfunction, Left; Ventricular Function, Left; Vildagliptin | 2018 |
Paeoniflorin improves cardiac function and decreases adverse postinfarction left ventricular remodeling in a rat model of acute myocardial infarction.
Topics: Acute Disease; Animals; Apoptosis; Disease Models, Animal; Glucosides; Heart Function Tests; Male; Monoterpenes; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Empagliflozin normalizes the size and number of mitochondria and prevents reduction in mitochondrial size after myocardial infarction in diabetic hearts.
Topics: Animals; Autophagy; Benzhydryl Compounds; Blood Glucose; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Glucosides; Male; Microscopy, Electron; Mitochondria, Heart; Mitochondrial Proteins; Mitochondrial Size; Myocardial Infarction; Myocytes, Cardiac; Rats, Inbred OLETF; Reactive Oxygen Species; Sodium-Glucose Transporter 2 Inhibitors; Triglycerides; Vacuoles | 2018 |
Dual inhibition of sodium-glucose linked cotransporters 1 and 2 exacerbates cardiac dysfunction following experimental myocardial infarction.
Topics: Animals; Benzhydryl Compounds; Carbonates; Disease Models, Animal; Glucosides; Hypertrophy, Left Ventricular; Male; Myocardial Infarction; Myocardium; Rats, Inbred F344; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2018 |
Polydatin protects against acute myocardial infarction-induced cardiac damage by activation of Nrf2/HO-1 signaling.
Topics: Acute Disease; Animals; Apoptosis; Drugs, Chinese Herbal; Glucosides; Humans; Male; Myocardial Infarction; Myocytes, Cardiac; NF-E2-Related Factor 2; Protective Agents; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Signal Transduction; Stilbenes | 2019 |
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats.
Topics: Animals; Antioxidants; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucosides; Male; Metabolome; Myocardial Infarction; Rats; Rats, Inbred OLETF; Rats, Long-Evans; Sodium-Glucose Transporter 2 Inhibitors | 2019 |
Delayed ischaemic contracture onset by empagliflozin associates with NHE1 inhibition and is dependent on insulin in isolated mouse hearts.
Topics: Animals; Benzhydryl Compounds; Disease Models, Animal; Glucosides; Guanidines; Insulin; Isolated Heart Preparation; Male; Mice, Inbred C57BL; Myocardial Contraction; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Signal Transduction; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Hydrogen Exchanger 1; Sulfones; Time Factors | 2019 |
Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.
Topics: Animals; Benzhydryl Compounds; Echocardiography; Energy Metabolism; Glucosides; Heart Failure; Myocardial Infarction; Rats; Sodium-Glucose Transporter 2 Inhibitors; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
Diving into the unknown: sodium-glucose cotransporter-2 inhibitors in heart failure without diabetes.
Topics: Animals; Benzhydryl Compounds; Diabetes Mellitus, Type 2; Glucose; Glucosides; Heart Failure; Myocardial Infarction; Rats; Sodium; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Ventricular Dysfunction, Left | 2019 |
Dietary flaxseed protects against ventricular arrhythmias and left ventricular dilation after a myocardial infarction.
Topics: alpha-Linolenic Acid; Animals; Arrhythmias, Cardiac; Body Weight; Butylene Glycols; Cardiotonic Agents; Dietary Supplements; Electrocardiography; Fatty Acids; Flax; Glucosides; Male; Myocardial Infarction; Myocarditis; Organ Size; Rats, Sprague-Dawley; Ventricular Remodeling | 2019 |
Reconceptualization of the Molecular Mechanism by Which Sodium-Glucose Cotransporter 2 Inhibitors Reduce the Risk of Heart Failure Events.
Topics: Benzhydryl Compounds; Blood Volume; Death, Sudden, Cardiac; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Diuretics; Glucose; Glucosides; Heart Failure; Hospitalization; Humans; Hypoglycemic Agents; Kidney Tubules, Proximal; Multicenter Studies as Topic; Myocardial Infarction; Natriuresis; Randomized Controlled Trials as Topic; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Sodium-Hydrogen Exchanger 1; Stroke; Stroke Volume | 2019 |
Cardioprotective effect of resveratrol and resveratroloside.
Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Glucosides; Infusions, Parenteral; Male; Myocardial Infarction; Rats; Rats, Wistar; Reference Standards; Resveratrol; Stilbenes; Treatment Outcome | 2013 |
Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes.
Topics: Amputation, Surgical; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Body Weight; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Retinopathy; Disease Progression; Glucosides; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Kidney Failure, Chronic; Metformin; Microcirculation; Middle Aged; Myocardial Infarction; Nutrition Surveys; Sodium-Glucose Transporter 2 Inhibitors; Stroke; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome; Uric Acid | 2014 |
Cardioprotective effect of polydatin on ventricular remodeling after myocardial infarction in coronary artery ligation rats.
Topics: Aldosterone; Animals; Antioxidants; Captopril; Collagen; Coronary Occlusion; Coronary Vessels; Endothelin-1; Glucosides; Heart Ventricles; Hydroxyproline; Hypertrophy; Male; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric Oxide; Phytotherapy; Plant Extracts; Polygonum; Rats, Sprague-Dawley; Renin-Angiotensin System; Stilbenes; Ventricular Remodeling | 2015 |
Paeoniflorin ameliorates acute myocardial infarction of rats by inhibiting inflammation and inducible nitric oxide synthase signaling pathways.
Topics: Acute Disease; Animals; Anti-Inflammatory Agents; Caspase 3; Caspase 9; Creatine Kinase; Creatine Kinase, MB Form; Cytokines; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glucosides; Inflammation; L-Lactate Dehydrogenase; Medicine, Chinese Traditional; Monoterpenes; Myocardial Infarction; NF-kappa B; Nitric Oxide Synthase Type II; Paeonia; Rats; Rats, Sprague-Dawley; Signal Transduction; Troponin T | 2015 |
Calycosin‑7‑O‑β‑D‑glucoside attenuates ischemia‑reperfusion injury in vivo via activation of the PI3K/Akt pathway.
Topics: Animals; Apoptosis; Chromones; Creatine Kinase; Enzyme Activation; Glucosides; Isoflavones; L-Lactate Dehydrogenase; Male; Morpholines; Myocardial Infarction; Myocardial Reperfusion Injury; Oxidative Stress; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats, Wistar; Signal Transduction | 2016 |
Cardiac stem cell transplantation with 2,3,5,4'-tetrahydroxystilbehe-2-O-β-d-glucoside improves cardiac function in rat myocardial infarction model.
Topics: Animals; Disease Models, Animal; Glucosides; Heart Rate; Male; Myocardial Infarction; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Stem Cell Transplantation; Stilbenes | 2016 |
Polydatin protects cardiomyocytes against myocardial infarction injury by activating Sirt3.
Topics: Animals; Apoptosis; Disease Models, Animal; Glucosides; Mice; Mice, Knockout; Mitochondria, Heart; Myocardial Infarction; Myocytes, Cardiac; Organelle Biogenesis; Sirtuin 3; Stilbenes | 2017 |
Dapagliflozin, a selective SGLT2 Inhibitor, attenuated cardiac fibrosis by regulating the macrophage polarization via STAT3 signaling in infarcted rat hearts.
Topics: Animals; Benzhydryl Compounds; Fibrosis; Gene Expression Regulation; Glucosides; Humans; Interleukin-10; Macrophages; Myocardial Infarction; Myocardium; Rats; Reactive Oxygen Species; Signal Transduction; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; STAT3 Transcription Factor | 2017 |
Effect of Guanxin No.2 decoction on gene expression in different areas of the myocardial infarcted heart of rats using microarray technology.
Topics: Animals; Benzaldehydes; Benzoates; Benzofurans; Bridged-Ring Compounds; Cardiotonic Agents; Carthamus tinctorius; Catechols; Chalcone; Coumaric Acids; Dalbergia; Drugs, Chinese Herbal; Gene Expression; Gene Expression Profiling; Glucosides; Heart Ventricles; Hydroxybenzoates; Lactates; Ligusticum; Male; Monoterpenes; Myocardial Infarction; Oligonucleotide Array Sequence Analysis; Paeonia; Plant Extracts; Quinones; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Salvia miltiorrhiza | 2009 |
Effects of Radix et Rhizoma Rhodiolae Kirilowii on expressions of von Willebrand factor, hypoxia-inducible factor 1 and vascular endothelial growth factor in myocardium of rats with acute myocardial infarction.
Topics: Animals; Drugs, Chinese Herbal; Glucosides; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Myocardial Infarction; Myocardium; Phenols; Phytotherapy; Rats; Rats, Wistar; Rhizome; Rhodiola; RNA, Messenger; Vascular Endothelial Growth Factor A; von Willebrand Factor | 2009 |
Protective roles of cornuside in acute myocardial ischemia and reperfusion injury in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cornus; Disease Models, Animal; Drugs, Chinese Herbal; Glucosides; Heart; Hemodynamics; Inflammation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Phytotherapy; Plants, Medicinal; Pyrans; Rats; Rats, Sprague-Dawley | 2011 |
A strategy for detecting optimal ratio of cardioprotection-dependent three compounds as quality control of guan-xin-er-hao formula.
Topics: Animals; Apoptosis; Benzaldehydes; Benzoates; Bridged-Ring Compounds; Cardiotonic Agents; Caspase 3; Catechols; Chalcone; Chemistry, Pharmaceutical; Coumaric Acids; Drugs, Chinese Herbal; Ethnopharmacology; Glucosides; Male; Monoterpenes; Myocardial Infarction; Phytotherapy; Quality Control; Quinones; Rats; Rats, Sprague-Dawley | 2011 |
Cardioprotection with 8-O-acetyl shanzhiside methylester on experimental myocardial ischemia injury.
Topics: Animals; Cardiotonic Agents; Cells, Cultured; Collagen; Glucosides; HMGB1 Protein; Hypoxia; Inflammation; Interleukin-6; Male; Myocardial Infarction; Myocardial Reperfusion Injury; NF-kappa B; Phosphorylation; Pyrans; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2012 |
Secoisolariciresinol diglucoside: relevance to angiogenesis and cardioprotection against ischemia-reperfusion injury.
Topics: Animals; Apoptosis; Butylene Glycols; Cells, Cultured; Echocardiography; Glucosides; Humans; Male; Morphogenesis; Myocardial Infarction; Myocardial Reperfusion Injury; Myocytes, Cardiac; Neovascularization, Physiologic; Nitric Oxide; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Sprague-Dawley | 2007 |
Secoisolariciresinol diglucoside induces neovascularization-mediated cardioprotection against ischemia-reperfusion injury in hypercholesterolemic myocardium.
Topics: Animals; Blood Vessels; Blotting, Western; Butylene Glycols; Cardiotonic Agents; Coronary Vessels; Glucosides; Heart Function Tests; Heme Oxygenase-1; Hypercholesterolemia; Lipid Metabolism; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Phosphoproteins; Rats; Rats, Sprague-Dawley; Ultrasonography; Vascular Endothelial Growth Factor A | 2008 |
Protective effect of polydatin against ischemia/reperfusion injury in rat heart.
Topics: Animals; Glucosides; Heart; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Stilbenes; Superoxide Dismutase | 2008 |
Anturan for secondary prophylaxis of myocardial infarction.
Topics: Adrenergic beta-Antagonists; Diuretics; Drug Therapy, Combination; Female; Glucosides; Humans; Male; Middle Aged; Myocardial Infarction; Sulfinpyrazone | 1988 |